首页|硫酸镁联合阿司匹林治疗妊娠期高血压效果观察及其对胎盘HIF-1α的影响

硫酸镁联合阿司匹林治疗妊娠期高血压效果观察及其对胎盘HIF-1α的影响

Efficacy of magnesium sulfate plus aspirin in the treatment of pregnancy-induced hypertension and its effect on placental hypoxia-induced factor-1α levels

扫码查看
目的 观察硫酸镁联合阿司匹林治疗妊娠期高血压的疗效及其对胎盘缺氧诱导因子1α(HIF-1α)表达水平的影响.方法 采用病例对照研究,选取嘉兴市妇幼保健院2019年1月至2023年1月收治的妊娠期高血压患者96例的临床资料,按照治疗方式将其分为对照组、研究组各48例.对照组采用硫酸镁治疗,研究组采用硫酸镁联合阿司匹林治疗,两组患者治疗14 d.比较两组临床疗效,治疗前后血压、胎盘HIF-1α和内皮素水平,观察两组不良反应及不良妊娠结局发生率.结果 研究组有效率为93.8%(45/48),高于对照组的79.2%(38/48),差异有统计学意义(x2=4.36,P<0.05).治疗后,研究组舒张压、收缩压均低于对照组(t=5.70、7.33,均P<0.05);研究组胎盘HIF-1α、内皮素分别为(41.03±6.95)µg/L、(93.37+8.29)ng/L,均低于对照组的(82.97±8.86)µg/L、(124.96±9.32)ng/L,差异均有统计学意义(t=17.55、25.80,均P<0.001).研究组不良反应、不良妊娠结局发生率分别为12.5%(6/48)、10.4%(5/48),均低于对照组的31.3%(15/48)、27.1%(13/48),差异均有统计学意义(x2=4.94、4.38,均P<0.05).结论 硫酸镁联合阿司匹林治疗妊娠期高血压有显著的临床疗效,能够降低患者的舒张压、收缩压、胎盘HIF-1α和内皮素水平,且可降低不良反应和不良妊娠结局发生率.
Objective To investigate the efficacy of magnesium sulfate plus aspirin in the treatment of pregnancy-induced hypertension and its effect on placental hypoxia-induced factor-1α(HIF-1α)levels.Methods This is a case-control study.The clinical data were collected from 96 patients with gestational hypertension who were admitted to Jiaxing Maternity and Child Health Care Hospital between January 2019 and January 2023.These patients were divided into a control group and a study group,with 48 patients in each group,according to different treatment methods.The control group received magnesium sulfate treatment,whereas the study group was treated with magnesium sulfate combined with aspirin.Both groups were treated for 14 days.The clinical efficacy of the two groups was compared.Pre-and post-treatment blood pressure,placental HIF-1αlevels,and endothelin levels were compared between the two groups.The incidence of adverse reactions and adverse pregnancy outcomes were also compared between the two groups.Results The response rate in the study group was significantly higher compared with that in the control group,with 93.8%(45/48)versus 79.2%(38/48),respectively(x2=4.36,P<0.05).Following treatment,both diastolic and systolic blood pressure levels in the study group were significantly lower than those in the control group(t=5.70,7.33,both P<0.05).Placental HIF-1α and endothelin levels in the study group were(41.03±6.95)μg/L and(93.37±8.29)ng/L,respectively,which were significantly lower than those in the control group[(82.97±8.86)μg/L,(124.96±9.32)ng/L,t=17.55,25.80,both P<0.001].The incidences of adverse reactions and unfavorable pregnancy outcomes in the study group were 12.5%(6/48)and 10.4%(5/48),respectively.These were significantly lower compared with those in the control group,which were 31.3%(15/48)and 27.1%(13/48),respectively(x2=4.94,4.38,both P<0.05).Conclusion Magnesium sulfate combined with aspirin is highly effective in treating pregnancy-induced hypertension.This combined therapy can effectively lower patients'diastolic and systolic blood pressures,as well as placental HIF-1α and endothelin levels.It can obviously reduce the incidences of adverse reactions and unfavorable pregnancy outcomes.

Hypertension,pregnancy-inducedDrug therapy,combinationMagnesium sulfateAspirinBlood pressureHypoxia-inducible factor 1,alpha subunitPregnancy outcome

陈芸、沈清、唐建芬

展开 >

嘉兴市妇幼保健院产科,嘉兴 314000

高血压,妊娠性 药物疗法,联合 硫酸镁 阿司匹林 血压 缺氧诱导因子1,α亚基 妊娠结局

2024

中国基层医药
中华医学会,安徽医科大学

中国基层医药

影响因子:1.003
ISSN:1008-6706
年,卷(期):2024.31(7)
  • 10